E2F1 and Burkitt lymphoma: Together, E2F and MYC may activate several genes in a coordinated way, as demonstrated by enrichment for E2F1 binding sites in P493-6 B-cells, a BL model cell line in which MYC is expressed under the control of a tetracycline-regulated promoter [131].